Thryvv : ratio page

Alkem Laboratories

Overview Articles Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2025
Mar2024
Mar2023
Mar2022
Mar2021
Valuation Parameters:
PE(x)
26.94
32.89
41.27
26.28
20.91
PCE(x)
22.67
27.98
30.84
21.79
17.51
Price/Book(x)
4.88
5.74
4.49
5.01
4.49
Yield(%)
0.92
0.81
1.47
0.94
1.08
EV/Net Sales(x)
4.46
4.63
3.39
4.07
3.71
EV/Core EBITDA(x)
19.24
22.96
21.53
19.52
15.10
EV/EBIT(x)
21.84
27.48
27.84
22.80
17.28
EV/CE(x)
4.43
5.09
3.80
3.39
3.16
MCap / Sales
4.50
4.66
3.50
4.07
3.74
Growth Ratio:
Net Sales Growth(%)
2.34
9.21
9.08
19.96
6.24
Core EBITDA Growth(%)
17.59
40.03
-17.60
1.84
37.90
EBIT Growth(%)
24.03
51.23
-25.55
-0.23
43.49
PAT Growth(%)
22.33
79.92
-40.08
3.87
40.76
EPS Growth(%)
20.59
82.47
-40.19
3.82
40.63
Financial Stability Ratios:
Total Debt/Equity(x)
0.09
0.12
0.14
0.30
0.23
Current Ratio(x)
2.73
2.61
2.32
1.76
1.92
Quick Ratio(x)
1.99
1.94
1.62
1.13
1.28
Interest Cover(x)
21.76
19.00
13.15
36.22
32.26
Total Debt/Mcap(x)
0.02
0.02
0.03
0.06
0.05
Operational & Financial Ratios:
Earnings Per Share (Rs)
181.14
150.21
82.32
137.65
132.58
CEPS(Rs)
215.24
176.56
110.18
165.98
158.29
DPS(Rs)
45.00
40.00
50.00
34.00
30.00
Book NAV/Share(Rs)
999.47
860.94
756.56
722.48
616.95
Tax Rate(%)
12.31
10.46
22.84
8.89
12.18
Margin Ratios:
Core EBITDA Margin(%)
13.01
11.58
8.97
13.44
14.82
EBIT Margin(%)
13.72
11.02
7.87
12.42
14.50
Pre Tax Margin(%)
13.09
10.44
7.27
12.07
14.05
PAT Margin (%)
11.48
9.35
5.61
11.00
12.34
Cash Profit Margin (%)
13.33
10.89
7.34
12.99
14.43
Performance Ratios:
ROA(%)
14.77
13.66
7.99
14.50
16.66
ROE(%)
19.93
18.74
11.39
20.99
23.91
ROCE(%)
21.56
19.52
13.09
18.69
22.56
Asset Turnover(x)
1.29
1.46
1.42
1.32
1.35
Sales/Fixed Asset(x)
4.17
4.51
4.36
3.86
3.58
Working Capital/Sales(x)
2.82
3.02
3.66
4.21
3.95
Efficiency Ratios:
Fixed Capital/Sales(x)
0.24
0.22
0.23
0.26
0.28
Receivable days
44.62
41.28
40.86
41.72
45.33
Inventory Days
52.79
49.60
57.10
63.54
57.51
Payable days
158.86
122.87
97.40
114.79
118.18